Zydus Therapeutics has racked up a…
Zydus Therapeutics has racked up a phase 2b/3 win in [...]
Flying high after an FDA approval…
Flying high after an FDA approval four months ago to [...]
Amid a growing push for more…
Amid a growing push for more direct-to-consumer access to some [...]
Pfizer is taking a curtain call…
Pfizer is taking a curtain call for Vyndaqel, the low-dose [...]
The University of Michigan is…
The University of Michigan is suing AstraZeneca over claims that [...]
Fosun Pharma has penned its third…
Fosun Pharma has penned its third inflammatory disease pact in [...]
A phase 1/2 trial of BeOne…
A phase 1/2 trial of BeOne Medicines’ sonrotoclax has hit [...]
Patients in the U.S. now have…
Patients in the U.S. now have access to the first [...]
The Leukemia & Lymphoma…
The Leukemia & Lymphoma Society is marking Blood Cancer Awareness [...]
The private equity-owned company…
The private equity-owned company held off on a previously planned [...]